Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-
dependent dementia. There is currently no effective treatment for AD, which may be …

Alzheimer's disease (AD), a neurodegenerative brain disorder that affects millions of people
worldwide, is characterized by memory loss and cognitive decline. Low levels of …

Background The immune system has been implicated in synaptic plasticity, inflammation,
and the progression of Alzheimer's disease (AD). However, there were few studies on …

Aim Ischemic damage to the brain is linked to an increased rate of morbidity and mortality
worldwide. In certain parts of the world, it remains a leading cause of mortality and the …

In recent years, there has been increasing research interest in the correlation between
hearing impairment and cognitive decline, two conditions that have demonstrated a strong …

Synaptic dysfunction and loss occur in Alzheimer's disease (AD) brains, which results in
cognitive deficits and brain neurodegeneration. Neuropeptides comprise the major group of …

Noise as an environmental stressor becomes of increasing importance in our industrialized
world, and especially traffic noise from the environment represents a potential novel …

Aims Delayed neurocognitive recovery (dNCR) is a common postoperative complication in
geriatric surgical patients for which there is no efficacious therapy. Cholecystokinin …

Introduction: Alzheimer's disease (AD) is a progressive neurodegenerative disease
accompanying memory deficits. The available pharmaceutical care has some limitations …

Alzheimer's Disease (AD) is a neurodegenerative disease featured by cognitive impairment.
This bioinformatic analysis was used to identify hub genes related to cognitive dysfunction in …